DJO Global Inc announces that OaraScore, its patient risk assessment algorithm, now will be available with a 6-month free trial for all new users.

OaraScore is a software tool designed to provides medical professionals with the information they need to predict which patients are most medically appropriate for an outpatient total joint arthroplasty (TJA) procedure. This trial program will enable any surgeon, clinic or hospital to optimize patient selection, according to the Lewisville, Tex-based company in a news release.

“The recent healthcare crisis dramatically increases the need for elective surgeries to be done in an outpatient or same-day discharge basis, including total joint arthroplasty,” Brady Shirley, CEO of DJO, says in the release.

“OaraScore is the most predictive, risk management tool designed specifically for total joint arthroplasty procedures to help ensure patients are cleared for outpatient surgery. It’s a clinically proven tool that surgeons can seamlessly integrate into their practice and experience immediate patient safety benefits.”

The OaraScore utilizes a validated, multi-disciplinary algorithm that was featured in a peer-reviewed study published in The Journal of Arthroplasty in August 2017 by Dr Michael Meneghini, director of the Indiana University Health Hip and Knee Center. The retrospective study revealed a patient’s OaraScore for total joint replacement more precisely predicted the ability for the patient to discharge home the same day or the next morning than existing risk tools, such as ASA and CCI.

“For the foreseeable future, it may be more realistic and appropriate for relatively healthy patients to avoid in-patient hospital stays, and it’s reassuring for surgeons to have a tool like OaraScore that can help safely transition many total joint arthroplasty patients into a more appropriate outpatient or same-day discharge pathway,” Meneghini comments.

The clinical benefits of the OaraScore have been independently validated in an AAHKS podium presentation by Duke University researchers in 2016 and in an independent study by New York University Langone Medical Center published in The Journal of Arthroplasty in August 2018.

For more information, or to register for free trial access to the OaraScore, visit DJO Global Inc.

[Source(s): DJO Global Inc, Business Wire]